RENAL CELL CARCINOMA (RCC)
Clinical trials for RENAL CELL CARCINOMA (RCC) explained in plain language.
Never miss a new study
Get alerted when new RENAL CELL CARCINOMA (RCC) trials appear
Sign up with your email to follow new studies for RENAL CELL CARCINOMA (RCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Dual-Action drug shows promise for kidney cancer patients
Disease control ENROLLING_BY_INVITATIONThis study tests a new medicine called AK112 for people with advanced kidney cancer that has spread. The drug works by helping the immune system fight cancer and blocking blood vessels that feed tumors. About 60 patients will receive the drug every three weeks to see if it shrink…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 17, 2026 00:44 UTC
-
Virus-Immunotherapy combo takes on tough cancers
Disease control OngoingThis study tests a cancer-killing virus (VSV-IFNβ-NIS) given with an immunotherapy drug (pembrolizumab) in people with advanced solid tumors, including non-small cell lung cancer, neuroendocrine cancer, and kidney cancer. The goal is to find the safest and most effective virus do…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE1, PHASE2 • Sponsor: Vyriad, Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New cancer drug AB598 enters early human safety testing
Disease control OngoingThis early-phase study tests the safety of a new drug called AB598, given alone or with other treatments, in about 40 people with advanced solid tumors (e.g., lung, bladder, breast, or ovarian cancer). The main goal is to see if the drug is safe and tolerable. Participants must h…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Blood test may predict immunotherapy success in cancer patients
Knowledge-focused OngoingThis study is looking at whether changes in a blood test called tumor fraction can help predict how well immunotherapy works in people with non-small cell lung cancer or kidney cancer. About 100 adults are taking part, and researchers will also look at inflammation, hormone level…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 11, 2026 20:40 UTC